Character Biosciences’ Post

Excited to leverage our unique patient data platform in this collaboration with Bausch + Lomb. It has been a remarkable journey for our team developing a multi-omic and multi-modal platform of longitudinal real-world data from individuals suffering with dry AMD across the United States. We embed deep patient phenotyping within this framework through computer vision models that quantify nuanced growth of digital biomarkers derived from imaging. Looking forward to combining our deep phenotyping capabilities with B+L's expertise to accelerate the development of precision treatments for patients with AMD. #AMD #MachineLearning #ComputerVision #ClinicalInformatics #PrecisionMedicine #DrugDiscovery

I'm happy to share this groundbreaking collaboration between Character Bio and @Bausch + Lomb. By integrating our genetics-guided drug discovery platform and stellar drug discovery team with B+L’s deep expertise in ophthalmology development, we’re pioneering a data-driven approach to understand the underlying mechanisms of AMD. This collaboration exemplifies how AI-powered analytics and multi-modal patient data can accelerate the development of precision medicines, potentially transforming treatment options for patients with age-related macular degeneration.

Proud to present two free papers at the 67th Portuguese Ophthalmology Conference! The first demonstrates the cost-effectiveness of AI-based glaucoma screening, showing we can cut costs while providing care to a previously undiagnosed population. The second, developed with colleagues at Instituto Superior Técnico (Diogo Fróis Vieira & Mariana Dias Parrinha) introduces an algorithm to segment retinal detachments in VKH, serving as a potencial tool to identify novel biomarkers. #AI #Glaucoma #Ophthalmology #VKH #Retina

Important end point for clinical trials...Ellipsoid Zone loss....using these analyses, we will be able to identify early progressors and treatment response.

As a resident in ophthalmology, every day is a mix of excitement, learning, and commitment. The balance between clinical duties, surgeries, and staying updated on the latest research can be intense, but it’s driven by a passion for restoring sight and improving lives. One of the biggest challenges in ophthalmology is the delicate balance between precision and speed. Whether diagnosing complex retinal diseases or performing microsurgery, each step requires full focus and mastery. But that's what makes this field so rewarding—knowing that even the smallest interventions can have life-changing effects. Looking ahead, the future of ophthalmology is incredibly promising. From AI-powered diagnostics to advancements in gene therapy and minimally invasive procedures, the potential to revolutionize patient care is immense. It’s exciting to be at the forefront of a field that's constantly evolving! Here’s to all my colleagues and future ophthalmologists—let’s continue pushing boundaries and making a difference! 🙌 #Ophthalmology #ResidentLife #MedicalInnovation #FutureOfHealthcare #SurgicalPrecision

Our latest abstract, published in the Association for Research in Vision and Ophthalmology (ARVO) IOVS Journal (June 2024), reveals a correlation between OCT and FAF measurements for GA lesions, with RPE and PR loss serving as reliable biomarkers for assessing GA. With our advanced OCT segmentation model in Research Use Only, physicians can now automatically detect and measure RPE and PR loss, making pre-screening and screening in clinical trials faster and more precise. Read the full abstract on our website, and see how we are redefining retinal imaging and analysis 👉 https://lnkd.in/eHcpRJmt

👁 Unlock the potential of zebrafish models in advancing ophthalmology research! Explore their genetic parallels to humans and their role in behavioral visual assessments. 🐟 Dive into this insightful blog article to uncover how zebrafish are shaping the future of eye disease treatments. Don't miss out! 👉 https://bit.ly/3WnsrM8 #OphthalmologyResearch #Zebrafish #DrugDiscovery

🚀 Discover the latest breakthroughs from EHA 2024! Dr Marie Vercruyssen from the Institut Jules Bordet in Brussels presents the outcomes of the IMROZ trial. This study evaluated adding isatuximab to the VRd regimen in transplant-ineligible multiple myeloma patients, showing significant improvements in progression-free survival (PFS) and minimal residual disease (MRD) negativity. The Isa-VRd regimen could become a new standard of care for these patients. For all EHA 2024 videos, find the link in the comments! 👇 #MediMix #Hematology #MultipleMyeloma #ClinicalTrials #Innovation

🌟 **Medical Breakthrough: Artificial Cornea Restores Vision to Legally Blind Man** 🌟 I'm thrilled to share an inspiring story of innovation and hope! An artificial cornea, developed by company CorNeat Vision, has been successfully implanted in the eye of a 78-year-old man who had been legally blind for a decade. The CorNeat KPro device has restored his vision, marking a significant milestone in ophthalmology and offering new possibilities for those suffering from corneal blindness. This breakthrough underscores the incredible potential of medical technology to transform lives. Kudos to the brilliant minds at CorNeat Vision for their dedication and ingenuity. This is a testament to the power of science and innovation in improving human health and well-being. #MedicalInnovation #Ophthalmology #CorNeatVision #Healthcare #MedicalTechnology #Inspiration #MedicalLaboratoryTechnology #Microbiology #Phlebotomy #LaboratoryTesting #DiagnosticTesting #HealthcareProfessional #MedicalTesting #ClinicalLaboratory #BiomedicalScience #HealthcareIndustry #MedicalScience #LaboratoryMedicine #ClinicalMicrobiology #InfectionControl #PhlebotomyTechnician #MedicalLabTechnician #MicrobiologyLab #ClinicalLab #HealthcareCareer #MedicalCareer #ScienceCareer #COVID19Testing #Virology #Bacteriology #Parasitology #MolecularDiagnosis #GeneticTesting #Cytology #Histopathology #Immunology #Serology

Regulators are asking for a central review of #Imaging evaluation to mitigate data variability in #Myeloma #ClinicalTrials. Stay current on imaging trends that could affect your #ClinicalDevelopment in this Flash Update by Calyx’s @Surabhi Bajpai. https://lnkd.in/eR5hKkye #MedicalImaging #Hematology #HemOnc